{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:54:22Z","timestamp":1791114862731,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"39","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dutch Ministry of Economic Affairs"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.07.037","type":"journal-article","created":{"date-parts":[[2014,7,19]],"date-time":"2014-07-19T10:00:17Z","timestamp":1405764017000},"page":"4901-4908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Comparative efficacy of two next-generation Rift Valley fever vaccines"],"prefix":"10.1016","volume":"32","author":[{"given":"J.","family":"Kortekaas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Oreshkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"van Keulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bouloy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Goovaerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.M.","family":"Moormann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.07.037_bib0005","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.coviro.2012.02.017","article-title":"Breaking the chain: Rift Valley fever virus control via livestock vaccination","volume":"2","author":"Bird","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0010","first-page":"1","article-title":"Rift Valley fever; the neurotropic adaptation of the virus and the experimental use of this modified virus as a vaccine","volume":"30","author":"Smithburn","year":"1949","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-6-94","article-title":"Pathological studies on postvaccinal reactions of Rift Valley fever in goats","volume":"6","author":"Kamal","year":"2009","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0020","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jmv.20624","article-title":"Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine","volume":"78","author":"Botros","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0025","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1099\/0022-1317-66-10-2271","article-title":"Mutagen-directed attenuation of Rift Valley fever virus as a method for vaccine development","volume":"66","author":"Caplen","year":"1985","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0030","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0264-410X(90)90096-5","article-title":"Use of reassortant viruses to map attenuating and temperature-sensitive mutations of the Rift Valley fever virus MP-12 vaccine","volume":"8","author":"Saluzzo","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0035","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2460\/ajvr.1997.58.10.1110","article-title":"Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0040","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2460\/ajvr.1997.58.10.1104","article-title":"Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle","volume":"58","author":"Morrill","year":"1997","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0045","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.vaccine.2012.10.118","article-title":"Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheep","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0050","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2460\/ajvr.1987.48.07.1042","article-title":"Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes","volume":"48","author":"Morrill","year":"1987","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0055","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0264-410X(91)90314-V","article-title":"Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep","volume":"9","author":"Morrill","year":"1991","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0060","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.1016\/j.vaccine.2013.08.003","article-title":"Immunogenicity of a recombinant Rift Valley fever MP-12-NSm deletion vaccine candidate in calves","volume":"31","author":"Morrill","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0065","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.1995.53.405","article-title":"Characterization of Clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment","volume":"53","author":"Muller","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0070","doi-asserted-by":"crossref","first-page":"9798","DOI":"10.1128\/JVI.78.18.9798-9806.2004","article-title":"NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription","volume":"78","author":"Billecocq","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0075","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1128\/JVI.75.3.1371-1377.2001","article-title":"Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs","volume":"75","author":"Bouloy","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0080","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1371\/journal.ppat.0040013","article-title":"A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells","volume":"4","author":"Le May","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0092-8674(04)00132-1","article-title":"TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus","volume":"116","author":"Le May","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0090","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1128\/JVI.02255-10","article-title":"NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62","volume":"85","author":"Kalveram","year":"2011","journal-title":"J Virol"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2014.07.037_bib0095","doi-asserted-by":"crossref","first-page":"E75","DOI":"10.1111\/j.1749-6632.2009.05054.x","article-title":"Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR","volume":"1171","author":"Ikegami","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0100","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1128\/JVI.02148-08","article-title":"NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase","volume":"83","author":"Habjan","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0105","doi-asserted-by":"crossref","first-page":"11333","DOI":"10.1128\/JVI.01549-12","article-title":"Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome","volume":"86","author":"Benferhat","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0110","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1128\/JVI.01165-09","article-title":"Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects","volume":"84","author":"Mansuroglu","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0115","doi-asserted-by":"crossref","first-page":"e36327","DOI":"10.1371\/journal.pone.0036327","article-title":"p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production","volume":"7","author":"Austin","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0120","doi-asserted-by":"crossref","first-page":"7399","DOI":"10.1074\/jbc.M111.296608","article-title":"Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication","volume":"287","author":"Baer","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0125","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.1016\/j.vaccine.2010.04.085","article-title":"Evaluation of the efficacy and safety of the Rift Valley fever Clone 13 vaccine in sheep","volume":"28","author":"Dungu","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0130","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2011.05.055","article-title":"Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves","volume":"29","author":"von Teichman","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0135","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.antiviral.2009.08.002","article-title":"Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines","volume":"84","author":"Bouloy","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0140","doi-asserted-by":"crossref","first-page":"e77461","DOI":"10.1371\/journal.pone.0077461","article-title":"A single vaccination with an improved nonspreading rift valley Fever virus vaccine provides sterile immunity in lambs","volume":"8","author":"Oreshkova","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0145","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0168-1702(97)00097-X","article-title":"Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation","volume":"52","author":"Vialat","year":"1997","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0150","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1128\/JVI.74.3.1538-1543.2000","article-title":"The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice","volume":"74","author":"Vialat","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0155","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1099\/0022-1317-77-12-3053","article-title":"Persistent infection of mammalian cells by Rift Valley fever virus","volume":"77","author":"Billecocq","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0160","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Arch Exp Path Pharm"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0165","first-page":"227","article-title":"The method of right and wrong cases (constant stimuli) without Gauss's formulae","volume":"2","author":"Spearman","year":"1908","journal-title":"Br J Psych"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0170","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.1128\/JVI.00841-11","article-title":"Creation of a nonspreading Rift Valley fever virus","volume":"85","author":"Kortekaas","year":"2011","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0175","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1016\/j.vaccine.2012.03.027","article-title":"Efficacy of three candidate Rift Valley fever vaccines in sheep","volume":"30","author":"Kortekaas","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0180","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/JCM.40.7.2323-2330.2002","article-title":"Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR","volume":"40","author":"Drosten","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2014.07.037_bib0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1128\/JVI.58.2.263-270.1986","article-title":"Use of bacterial expression cloning to define the amino acid sequences of antigenic determinants on the G2 glycoprotein of Rift Valley fever virus","volume":"58","author":"Keegan","year":"1986","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14009785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T21:47:30Z","timestamp":1746308850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14009785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":37,"journal-issue":{"issue":"39","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14009785"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of two next-generation Rift Valley fever vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.07.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}